Changes include universal vaccination against hepatitis B for all adults aged 19 through 59 years and for at-risk older adults
Baricitinib Reduces Mortality in Critically Ill Adults With COVID-19
Reduction in death seen at 28, 60 days for patients receiving invasive mechanical ventilation, extracorporeal membrane oxygenation
Poor Outcomes Common With COVID-19, Acute Ischemic Stroke
Factors associated with poor functional outcomes included age older than 60 years, diabetes mellitus, increased NIHSS, LVO
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Feb. 14 to 18, 2022. This …
Scientists Report ‘Rogue Antibodies’ Behind Severe Clotting With COVID-19
Study authors suggest future research assess the potential benefits of screening COVID-19 patients for antiphospholipids and other autoantibodies
Adolescents and Children Immunization Schedules Updated for 2022
The U.S. CDC issued a Morbidity and Mortality Weekly Report today highlighting the Advisory Committee on Immunization Practices (ACIP) recommended immunization schedule for children and adolescents for 2022.
Found on the CDC’s immunization schedule website, the ACIP recommendations issued on February 18, 2022, include several changes from the 2021 immunization schedule.
Vaccine-specific changes include new or updated ACIP recommendations for influenza, dengue, and COVID-19 vaccines.
Consumers Want Choice of COVID Vaccines
More than one year after the first COVID-19 vaccine was administered in the United States, new data from a recent survey conducted online by The Harris Poll show 73% of consumers would like to see additional COVID-19 vaccines become available.
Currently, the World Health Organization has listed ten different COVID-19 vaccines based on various technologies.
But the U.S. FDA has only authorized/approved three COVID-19 vaccines.
COVID-19 Vaccination Safe During Pregnancy
No differences seen in neonatal and early infant outcomes for offspring exposed, not exposed to vaccine in utero
Younger Moms Most Hesitant to Vaccinating Children Against COVID-19
Findings based on survey of Medicaid enrollees in Florida
Humoral Response in Hemodialysis Patients Stronger With mRNA-1273
Antibody responses at six to seven and 12 weeks after the second dose stronger with mRNA-1273 versus BNT162b2